283 related articles for article (PubMed ID: 17877533)
21. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.
Weil RJ; Vortmeyer AO; Zhuang Z; Pack SD; Theodore N; Erickson RK; Oldfield EH
J Neurosurg; 2002 Apr; 96(4):775-87. PubMed ID: 11990821
[TBL] [Abstract][Full Text] [Related]
22. A genetic register for von Hippel-Lindau disease.
Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
[TBL] [Abstract][Full Text] [Related]
23. Expression of growth factors and growth factor receptors in capillary hemangioblastoma.
Böhling T; Hatva E; Kujala M; Claesson-Welsh L; Alitalo K; Haltia M
J Neuropathol Exp Neurol; 1996 May; 55(5):522-7. PubMed ID: 8627342
[TBL] [Abstract][Full Text] [Related]
24. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
25. An 11-bp duplication in the promoter region of the VHL gene in a patient with cerebellar hemangioblastoma and renal oncocytoma.
Muscarella LA; Barbano R; Augello B; Formica V; Micale L; Zelante L; D'Agruma L; Merla G
J Hum Genet; 2007; 52(6):485-491. PubMed ID: 17437055
[TBL] [Abstract][Full Text] [Related]
26. Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system.
Oberstrass J; Reifenberger G; Reifenberger J; Wechsler W; Collins VP
J Pathol; 1996 Jun; 179(2):151-6. PubMed ID: 8758206
[TBL] [Abstract][Full Text] [Related]
27. Developmental effects of von Hippel-Lindau gene deficiency.
Vortmeyer AO; Yuan Q; Lee YS; Zhuang Z; Oldfield EH
Ann Neurol; 2004 May; 55(5):721-8. PubMed ID: 15122713
[TBL] [Abstract][Full Text] [Related]
28. Von Hippel-Lindau disease: delayed presentation as a cerebellar haemangioblastoma in an elderly patient.
Shekhar H; Myles L; Lee M
Br J Neurosurg; 2009 Feb; 23(1):97-8. PubMed ID: 19234919
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
30. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Marti HH; Plate KH
Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
[TBL] [Abstract][Full Text] [Related]
32. Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.
Shively SB; Edwards NA; MacDonald TJ; Johnson KR; Diaz-Rodriguez NM; Merrill MJ; Vortmeyer AO
J Neuropathol Exp Neurol; 2022 Oct; 81(11):885-899. PubMed ID: 35980299
[TBL] [Abstract][Full Text] [Related]
33. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.
Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM
Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352
[TBL] [Abstract][Full Text] [Related]
34. [Haemangioblastomas: clinical, epidemiological and pathological findings in 14 cases].
Gasparetto EL; Faoro LN; Reis Filho JS; Torres LF
Arq Neuropsiquiatr; 2000 Jun; 58(2A):310-4. PubMed ID: 10849633
[TBL] [Abstract][Full Text] [Related]
35. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
[TBL] [Abstract][Full Text] [Related]
36. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
38. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
39. [Hemangioblastoma and von Hippel-Lindau disease].
Matsumoto K; Kannuki S
Nihon Rinsho; 1995 Nov; 53(11):2672-7. PubMed ID: 8538024
[TBL] [Abstract][Full Text] [Related]
40. [Von Hippel-Lindau syndrome with spinal, cerebellar, and retinal hemangioblastoma in identical twins].
Wessels T; Kemeny S; Block F
Nervenarzt; 2002 Dec; 73(12):1195-8. PubMed ID: 12486572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
